SCHEMBL8048848

SCHEMBL8048848

O=C(/C=C/c1ccc([N+](=O)[O-])cc1)Nc1cc(Cl)ccc1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK2 O95069 1/20 0.61
TRPA1 O75762 1/20 0.59
TRPM2 O94759 1/20 0.58
KMT2A Q03164 4/20 0.56
ALDH1A1 P00352 3/20 0.56
MAPT P10636 3/20 0.56
MEN1 O00255 2/20 0.56
POLB P06746 2/20 0.56
HPGD P15428 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
MAOB P27338 3/20 0.52
MAOA P21397 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
EGFR P00533 2/20 0.51
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
TRPV1 Q8NER1 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8048849 1.00 KCNK2 (0.61) KCNK2TRPA1TRPM2KMT2AALDH1A1
SCHEMBL8060535 0.91 TRPA1 (0.59) KCNK2TRPA1TRPM2KMT2AALDH1A1
SCHEMBL8060537 0.91 TRPA1 (0.59) KCNK2TRPA1TRPM2KMT2AALDH1A1
SCHEMBL8065895 0.88 TRPV1 (0.67) TRPM2KMT2AALDH1A1MAPTMEN1
SCHEMBL8065896 0.88 TRPV1 (0.67) TRPM2KMT2AALDH1A1MAPTMEN1
SCHEMBL8061586 0.88 TRPA1 (0.75) KCNK2TRPA1TRPM2KMT2AALDH1A1
SCHEMBL8061590 0.88 TRPA1 (0.75) KCNK2TRPA1TRPM2KMT2AALDH1A1
SCHEMBL2273179 0.84 TRPM2 (0.77) TRPA1TRPM2KMT2AALDH1A1MAPT
SCHEMBL2273176 0.84 TRPM2 (0.77) TRPA1TRPM2KMT2AALDH1A1MAPT
SCHEMBL8060350 0.84 TRPA1 (0.73) KCNK2TRPA1TRPM2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed